Ontology highlight
ABSTRACT: Objective
To determine the effectiveness and safety of perioperative tranexamic acid use in patients undergoing total hip or knee arthroplasty in the United States.Design
Retrospective cohort study; multilevel multivariable logistic regression models measured the association between tranexamic acid use in the perioperative period and outcomes.Setting
510 US hospitals from the claims based Premier Perspective database for 2006-12.Participants
872,416 patients who had total hip or knee arthroplasty.Intervention
Perioperative intravenous tranexamic acid use by dose categories (none, ≤ 1000 mg, 2000 mg, and ≥ 3000 mg).Main outcome measures
Allogeneic or autologous transfusion, thromboembolic complications (pulmonary embolism, deep venous thrombos
SUBMITTER: Poeran J
PROVIDER: S-EPMC4130961 | biostudies-literature | 2014 Aug
REPOSITORIES: biostudies-literature